企業プロフィール
Icosavax 株価・ニュース・カタリスト
- ティッカー:
- ICVX
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価変動の要因
Current closing-price context is not available for ICVX.
企業概要
事業概要
Icosavax was a vaccine biotechnology company focused on next-generation respiratory vaccines before its acquisition by AstraZeneca. Its platform combined structural biology and vaccine design.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ before acquisition, Icosavax sat in vaccine biotechnology.
ビジネスモデルの特徴
The business depended on clinical data, immunogenicity, and the value of its vaccine design platform.
バイオ業界での位置付け
Icosavax was a vaccine-platform name and now belongs to biotech M&A history.
今後のカタリスト
- Icosavax is now mostly a transaction closeout and integration story, so the remaining catalysts are any wind-down or post-deal milestone. There is no live standalone pipeline story left to drive the name.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。